センキウノリドHは,CXCR2を調節することによって,うつ病による乳がんの進行を逆転させる
Yingchao Wu1,2,3,4, Jiaqi Cui5, Liushan Chen1,2,3
1Chinese Medicine Guangdong Laboratory, Hengqin, 519031, Guangdong, China.
Natural products and bioprospecting
|August 21, 2025
まとめ
鬱病はIL-8とCXCR2を活性化することで 乳がんを悪化させます センキウノリドHはCXCR2を標的にし,うつ病患者の癌の成長を阻害する.
科学分野:
- 腫瘍学
- 神経科学
- 薬理学について
背景:
- うつ病は乳がんの進行を 増加させています
- 現在,うつ病に関連した乳がんに対する特定の治療目標や薬は存在しない.
研究 の 目的:
- うつ病に関連した乳がんの治療標的を特定する.
- 重要な遺伝子と乳がんの進行の因果関係を調べる
- うつ病に関連した乳がんの治療薬の検査
主な方法:
- 鬱病の乳がん患者で異なった発現遺伝子を特定するためのトランスクリプトミックの分析.
- 遺伝子と乳がんの因果関係を評価するメンデルのランダム化
- 治療用化合物を評価するための分子ドッキング,in vitro,およびin vivoの研究.
主要な成果:
- インタールイキン8 (IL-8) は,うつ病による乳がんの進行における重要な遺伝子として特定されました.
- 高いIL-8発現は,受容体CXCR2によって媒介される乳がんを因果的に促進する.
- センキウノリドHはCXCR2を調節し,腫瘍誘発効果を相殺することで,治療的可能性を示した.
結論:
- 鬱病はCXCR2のIL-8活性化によって乳がんの増殖を促進する.
- センキウノリドHはCXCR2を標的とし,うつ病のがん促進効果と乳がんの成長を抑制する.
関連する概念動画
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
G-protein Coupled Receptors
121.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


